<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Type 2 Diabetes Mellitus <-> Union of Lichen Simplex Chronicus, Prurigo Nodularis - Comorbidity</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        a {
            color: var(--primary-dark);
            text-decoration: none;
        }

        a:hover {
            text-decoration: underline;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.1rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .header-subtitle {
            margin-top: 12px;
            color: rgba(255,255,255,0.85);
            position: relative;
        }

        .header-dates {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 16px;
            padding-top: 12px;
            border-top: 1px solid rgba(255,255,255,0.22);
            position: relative;
        }

        .date-chip {
            display: inline-flex;
            align-items: center;
            gap: 6px;
            background: rgba(255,255,255,0.14);
            border: 1px solid rgba(255,255,255,0.25);
            border-radius: 999px;
            padding: 5px 10px;
            font-size: 0.82rem;
        }

        .date-chip-label {
            font-weight: 600;
            opacity: 0.95;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
            font-weight: 700;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-accent {
            background: #ede9fe;
            color: #5b21b6;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-weight: 600;
            margin-bottom: 4px;
        }

        .mapping-notes {
            font-size: 0.9rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .field {
            margin-top: 6px;
        }

        .field-label {
            font-weight: 600;
            margin-right: 6px;
        }

        .metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 10px;
            margin-top: 8px;
        }

        .metric {
            background: var(--bg);
            border: 1px solid var(--border);
            border-radius: 10px;
            padding: 8px 10px;
            font-size: 0.9rem;
        }

        .evidence {
            margin-top: 8px;
        }

        .evidence-item {
            border-left: 3px solid #94a3b8;
            padding-left: 10px;
            margin: 8px 0;
            color: var(--text-muted);
        }

        .evidence-item strong {
            color: var(--text);
        }

        .go-terms {
            margin: 8px 0 0;
            padding-left: 18px;
        }

        details {
            margin-top: 12px;
        }

        pre {
            background: #0f172a;
            color: #e2e8f0;
            padding: 12px;
            border-radius: 10px;
            overflow-x: auto;
            font-size: 0.85rem;
        }

        @media (max-width: 720px) {
            .page-header {
                padding: 28px 20px;
            }

            .page-header h1 {
                font-size: 1.7rem;
            }

            .section-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Comorbidity</span>
        </nav>

        <header class="page-header">
            <h1>Type 2 Diabetes Mellitus <-> Union of Lichen Simplex Chronicus, Prurigo Nodularis</h1>
            <div class="header-meta">
                <span class="badge badge-category">Comorbidity</span>
                
                <span class="badge badge-mondo">A_BEFORE_B</span>
                
                
                <span class="badge badge-category">CANDIDATE</span>
                
            </div>
            
            <div class="header-subtitle">Draft example based on EHR-derived Disease Trajectories (distraj). MONDO mapping TBD. Literature curation not started. E12 (malnutrition-related diabetes) may be a coding proxy for broader T2D biology in EHR signals.</div>
            
            
            <div class="header-dates">
                
                <span class="date-chip">
                    <span class="date-chip-label">Entry created</span>
                    <time datetime="2026-02-02T04:30:36Z">2026-02-02</time>
                </span>
                
                
                <span class="date-chip">
                    <span class="date-chip-label">Last updated</span>
                    <time datetime="2026-02-02T04:30:36Z">2026-02-02</time>
                </span>
                
            </div>
            
        </header>

        <div class="section-grid">
            <div class="card">
                <div class="card-header">
                    <div class="card-icon" style="background: #e0f2fe; color: #0369a1;">A</div>
                    <h2 class="card-title">Disease A</h2>
                </div>
                <div class="mapping-title">
                    
                    <a href="../disorders/Type_2_Diabetes_Mellitus.html">Type 2 Diabetes Mellitus</a>
                    
                </div>
                
                <div class="field"><span class="field-label">Slug:</span>Type_2_Diabetes_Mellitus</div>
                
                
                
            </div>
            <div class="card">
                <div class="card-header">
                    <div class="card-icon" style="background: #ede9fe; color: #6d28d9;">B</div>
                    <h2 class="card-title">Disease B</h2>
                </div>
                <div class="mapping-title">
                    
                    Union of Lichen Simplex Chronicus, Prurigo Nodularis
                    
                </div>
                
                
                <div class="field"><span class="field-label">Composition:</span>UNION</div>
                
                
                <div class="field"><span class="field-label">Components:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-parent"><a href="../disorders/Lichen_Simplex_Chronicus.html">Lichen_Simplex_Chronicus</a></span>
                        
                        
                        
                        <span class="tag tag-parent"><a href="../disorders/Prurigo_Nodularis.html">Prurigo_Nodularis</a></span>
                        
                        
                    </div>
                </div>
                
            </div>
        </div>

        
        <div class="card" id="signals">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">S</div>
                <h2 class="card-title">Association Signals</h2>
            </div>
            <div class="mapping-section">
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 1</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">DISEASE_TRAJECTORIES</span>
                        <span class="tag tag-classification">EHR_TEMPORAL_COMORBIDITY</span>
                        <span class="tag tag-mechanistic">A_BEFORE_B</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Austrian hospital stays (EHR-derived)</div>
                    
                    <div class="field"><span class="field-label">Demographics:</span>
                        Sex MALE
                        
                    </div>
                    
                    
                    <div class="field"><span class="field-label">Signal IDs:</span>
                        
                        <a href="https://bioregistry.io/ICD10:E12" target="_blank">ICD10:E12</a>
                        
                        
                         -> 
                        <a href="https://bioregistry.io/ICD10:L28" target="_blank">ICD10:L28</a>
                        
                    </div>
                    
                    
                    <div class="mapping-notes"><span class="field-label">Mapping notes:</span>ICD10:L28 groups lichen simplex chronicus and prurigo. ICD10:E12 (malnutrition-related diabetes) may be a proxy for broader T2D biology in this EHR signal.</div>
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 1.0
                        , B before A: 0.0
                        , Same time: 0.0
                    </div>
                    

                    
                    

                    
                    

                    
                    <div class="field"><span class="field-label">GO enrichment:</span>GO enrichment for shared disease-gene module (EHR-derived).</div>
                    <ul class="go-terms">
                        
                        <li>
                            
                            <a href="http://purl.obolibrary.org/obo/GO_0042593" target="_blank">Glucose homeostasis</a>
                            
                             (FDR 1.3316900932562692e-18)
                        </li>
                        
                        <li>
                            
                            <a href="http://purl.obolibrary.org/obo/GO_0032869" target="_blank">Cellular response to insulin stimulus</a>
                            
                             (FDR 2.6548646247194685e-11)
                        </li>
                        
                        <li>
                            
                            <a href="http://purl.obolibrary.org/obo/GO_0050796" target="_blank">Regulation of insulin secretion</a>
                            
                             (FDR 7.357708923593863e-11)
                        </li>
                        
                    </ul>
                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 2</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">LITERATURE_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">UNKNOWN</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Retrospective LSC cohort at a tertiary academic center (n=125).</div>
                    
                    
                    
                    <div class="mapping-notes"><span class="field-label">Mapping notes:</span>Signal pertains to the Lichen_Simplex_Chronicus component.</div>
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>PREVALENCE</strong>: 0.3</div>
                            
                            <div>CI:  - </div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Reported T2D prevalence in LSC cohort; comparator ~11% US adult population.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/40908757" target="_blank">PMID:40908757</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"type 2 diabetes (30% vs ~11%)."</div>
            
            
            <div>LSC cohort reported elevated T2D prevalence versus the general population.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 3</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">LITERATURE_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">UNKNOWN</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Korean dermatology outpatient cohort (PN; 2007-2020).</div>
                    
                    
                    
                    <div class="mapping-notes"><span class="field-label">Mapping notes:</span>Signal pertains to the Prurigo_Nodularis component.</div>
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>AOR</strong>: 1.37</div>
                            
                            <div>CI: 1.22 - 1.54</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Adjusted odds ratio for T2D in PN vs controls.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/35011837" target="_blank">PMID:35011837</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"type 2 diabetes mellitus (aOR, 1.37; 95% CI, 1.22-1.54)"</div>
            
            
            <div>PN outpatient cohort showed increased odds of T2D.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 4</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">LITERATURE_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">UNKNOWN</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>UK CPRD incident PN cohort (2008-2018).</div>
                    
                    
                    
                    <div class="mapping-notes"><span class="field-label">Mapping notes:</span>Signal pertains to the Prurigo_Nodularis component.</div>
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>RR</strong>: 1.836</div>
                            
                            <div>CI: 1.597 - 2.111</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Relative risk of T2D prevalence in PN vs matched controls.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/38024558" target="_blank">PMID:38024558</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"type 2 diabetes mellitus (RR = 1.836; 95% CI = 1.597-2.111)"</div>
            
            
            <div>UK CPRD cohort found higher T2D prevalence among PN patients.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
            </div>
        </div>
        

        
        <div class="card" id="hypotheses">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #1e40af;">H</div>
                <h2 class="card-title">Hypotheses</h2>
            </div>
            
            <div class="mapping-item">
                <div class="field">Hypothesis: shared neuroimmune itch–scratch axis (type 2 cytokines and neural sensitization) may link T2D with LSC/PN phenotypes.</div>
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/39217537" target="_blank">PMID:39217537</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: OTHER</div>
            
            
            <div>"The latest data indicate dysregulation of the neuroimmune axis in PN pathogenesis."</div>
            
            
            <div>Review evidence supports neuroimmune dysregulation in PN.</div>
            
        </div>
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/14756886" target="_blank">PMID:14756886</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: OTHER</div>
            
            
            <div>"Lichen simplex chronicus (LSC) of the anogenital area is an eczematous disease characterized by unremitting itching and scratching."</div>
            
            
            <div>Review evidence supports itch-scratch cycle centrality in LSC.</div>
            
        </div>
        
    </div>
    
    
                
                <div class="field"><span class="field-label">Pathophysiology:</span></div>
                
                <div class="field">
                    <strong>Neuroimmune dysregulation in pruritic dermatoses</strong>: Type 2 cytokines and neural sensitization may contribute to pruritic dermatoses in the context of metabolic disease.
                </div>
                
                <div class="field">
                    <span class="field-label">Cell types:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-parent">
                            <a href="http://purl.obolibrary.org/obo/CL_0000097" target="_blank">mast cell</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-parent">
                            <a href="http://purl.obolibrary.org/obo/CL_0000771" target="_blank">eosinophil</a>
                        </span>
                        
                        
                    </div>
                </div>
                
                
                
                
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/39217537" target="_blank">PMID:39217537</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: OTHER</div>
            
            
            <div>"The latest data indicate dysregulation of the neuroimmune axis in PN pathogenesis."</div>
            
            
            <div>Review evidence supports neuroimmune axis involvement in PN.</div>
            
        </div>
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/38345154" target="_blank">PMID:38345154</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: OTHER</div>
            
            
            <div>"Inflammatory cells, particularly mast cells and eosinophils,"</div>
            
            
            <div>PN review highlights mast cells and eosinophils in inflammatory infiltrates.</div>
            
        </div>
        
    </div>
    
    
                
                <div class="mapping-notes">Hypothesis only; evidence is mechanistic review-level, not causal.</div>
                
                
                <div class="field">
                    <strong>Itch-scratch cycle in lichen simplex chronicus</strong>: Persistent scratching and pruritus may drive lesion maintenance and neural sensitization.
                </div>
                
                
                
                
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/14756886" target="_blank">PMID:14756886</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: OTHER</div>
            
            
            <div>"Lichen simplex chronicus frequently persists as an itch-scratch cycle"</div>
            
            
            <div>Review evidence supports itch-scratch cycle in LSC.</div>
            
        </div>
        
    </div>
    
    
                
                <div class="mapping-notes">Hypothesis only; evidence is descriptive, not causal.</div>
                
                
                
            </div>
            
            <div class="mapping-item">
                <div class="field">Hypothesis: diabetic neuropathy and metabolic dysregulation increase chronic pruritus risk, promoting PN/LSC phenotypes in susceptible individuals. Evidence not yet curated.</div>
                
    
    
                
                <div class="field"><span class="field-label">Pathophysiology:</span></div>
                
                <div class="field">
                    <strong>Neuropathic itch in diabetes</strong>: Diabetes-related peripheral neuropathy may manifest as chronic itch that perpetuates scratching and lesion formation.
                </div>
                
                
                
                
                
    
    
                
                <div class="mapping-notes">Hypothesis only; evidence not yet curated.</div>
                
                
                
            </div>
            
            <div class="mapping-item">
                <div class="field">Hypothesis: type 2 inflammatory mediators elevated in T2D patients with chronic pruritus (IL-4, IL-13, GM-CSF, CXCL10) could promote pruritic dermatoses such as PN/LSC.</div>
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/36852577" target="_blank">PMID:36852577</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"Significantly higher levels of interleukin-4 (p = 0.004), interleukin-13 (p = 0.006), granulocyte-macrophage colony-stimulating factor (p &lt; 0.001) and C-X-C motif chemokine ligand 10 (p = 0.028) were observed in the patients with pruritus than in those without pruritus."</div>
            
            
            <div>T2D patients with pruritus show elevated type 2 and inflammatory mediators.</div>
            
        </div>
        
    </div>
    
    
                
                <div class="field"><span class="field-label">Pathophysiology:</span></div>
                
                <div class="field">
                    <strong>Type 2 inflammatory mediators in diabetic pruritus</strong>: Elevated type 2 and inflammatory mediators in T2D-associated pruritus may amplify neuroimmune itch signaling and sustain pruritic dermatoses.
                </div>
                
                
                <div class="field">
                    <span class="field-label">Biological processes:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-classification">
                            <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank">inflammatory response</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            <a href="http://purl.obolibrary.org/obo/GO_0019221" target="_blank">cytokine-mediated signaling pathway</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            <a href="http://purl.obolibrary.org/obo/GO_0070098" target="_blank">chemokine-mediated signaling pathway</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            <a href="http://purl.obolibrary.org/obo/GO_0070670" target="_blank">response to interleukin-4</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            <a href="http://purl.obolibrary.org/obo/GO_0035962" target="_blank">response to interleukin-13</a>
                        </span>
                        
                        
                    </div>
                </div>
                
                
                <div class="field">
                    <span class="field-label">Gene products:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-mechanistic">
                            <a href="http://purl.obolibrary.org/obo/NCIT_C20508" target="_blank">Interleukin-4</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-mechanistic">
                            <a href="http://purl.obolibrary.org/obo/NCIT_C20515" target="_blank">Interleukin-13</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-mechanistic">
                            <a href="http://purl.obolibrary.org/obo/NCIT_C20545" target="_blank">Granulocyte-Macrophage Colony-Stimulating Factor</a>
                        </span>
                        
                        
                        
                        <span class="tag tag-mechanistic">
                            <a href="http://purl.obolibrary.org/obo/NCIT_C28756" target="_blank">C-X-C Motif Chemokine 10</a>
                        </span>
                        
                        
                    </div>
                </div>
                
                
                <div class="field">
                    <span class="field-label">Mechanisms:</span>
                    <div class="tag-list">
                        
                        <span class="tag tag-accent">Interleukin-4 (IL-4)</span>
                        
                        <span class="tag tag-accent">Interleukin-13 (IL-13)</span>
                        
                        <span class="tag tag-accent">Granulocyte-macrophage colony-stimulating factor (GM-CSF)</span>
                        
                        <span class="tag tag-accent">CXCL10 (C-X-C motif chemokine ligand 10)</span>
                        
                    </div>
                </div>
                
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/36852577" target="_blank">PMID:36852577</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"Significantly higher levels of interleukin-4 (p = 0.004), interleukin-13 (p = 0.006), granulocyte-macrophage colony-stimulating factor (p &lt; 0.001) and C-X-C motif chemokine ligand 10 (p = 0.028) were observed in the patients with pruritus than in those without pruritus."</div>
            
            
            <div>Serum mediator elevations in pruritic T2D patients suggest inflammatory drivers.</div>
            
        </div>
        
    </div>
    
    
                
                
                
            </div>
            
        </div>
        

        

        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #fce7f3; color: #9d174d;">P</div>
                <h2 class="card-title">Shared Phenotypes</h2>
            </div>
            <ul class="go-terms">
                
                <li>
                    
                    <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank">
                        Pruritus
                    </a>
                    
                </li>
                
                <li>
                    
                    <a href="http://purl.obolibrary.org/obo/HP_0002360" target="_blank">
                        Sleep disturbance
                    </a>
                    
                </li>
                
                <li>
                    
                    <a href="http://purl.obolibrary.org/obo/HP_0100725" target="_blank">
                        Lichenification
                    </a>
                    
                </li>
                
                <li>
                    
                    <a href="http://purl.obolibrary.org/obo/HP_0200036" target="_blank">
                        Skin nodule
                    </a>
                    
                </li>
                
            </ul>
        </div>
        

        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e2e8f0; color: #334155;">Y</div>
                <h2 class="card-title">Raw YAML</h2>
            </div>
            <details>
                <summary>Show YAML</summary>
                <pre>name: com_Type_2_Diabetes_Mellitus__Lichen_Simplex_Chronicus__Prurigo_Nodularis
creation_date: &#39;2026-02-02T04:30:36Z&#39;
updated_date: &#39;2026-02-02T04:30:36Z&#39;
curation_status: CANDIDATE
notes: &gt;-
  Draft example based on EHR-derived Disease Trajectories (distraj). MONDO mapping
  TBD. Literature curation not started. E12 (malnutrition-related diabetes) may be
  a coding proxy for broader T2D biology in EHR signals.

disease_a:
  slug: Type_2_Diabetes_Mellitus

disease_b:
  composition: UNION
  components:
  - slug: Lichen_Simplex_Chronicus
  - slug: Prurigo_Nodularis

directionality: A_BEFORE_B

hypotheses:
- description: &gt;-
    Hypothesis: shared neuroimmune itch–scratch axis (type 2 cytokines and neural
    sensitization) may link T2D with LSC/PN phenotypes.
  evidence:
  - reference: PMID:39217537
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;The latest data indicate dysregulation of the neuroimmune axis in PN pathogenesis.&#34;
    explanation: Review evidence supports neuroimmune dysregulation in PN.
  - reference: PMID:14756886
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;Lichen simplex chronicus (LSC) of the anogenital area is an eczematous disease characterized by unremitting itching and scratching.&#34;
    explanation: Review evidence supports itch-scratch cycle centrality in LSC.
  pathophysiology:
  - name: Neuroimmune dysregulation in pruritic dermatoses
    description: &gt;-
      Type 2 cytokines and neural sensitization may contribute to pruritic
      dermatoses in the context of metabolic disease.
    notes: Hypothesis only; evidence is mechanistic review-level, not causal.
    cell_types:
    - preferred_term: mast cell
      term:
        id: CL:0000097
        label: mast cell
    - preferred_term: eosinophil
      term:
        id: CL:0000771
        label: eosinophil
    evidence:
    - reference: PMID:39217537
      supports: SUPPORT
      evidence_source: OTHER
      snippet: &#34;The latest data indicate dysregulation of the neuroimmune axis in PN pathogenesis.&#34;
      explanation: Review evidence supports neuroimmune axis involvement in PN.
    - reference: PMID:38345154
      supports: SUPPORT
      evidence_source: OTHER
      snippet: &#34;Inflammatory cells, particularly mast cells and eosinophils,&#34;
      explanation: PN review highlights mast cells and eosinophils in inflammatory infiltrates.
  - name: Itch-scratch cycle in lichen simplex chronicus
    description: &gt;-
      Persistent scratching and pruritus may drive lesion maintenance and
      neural sensitization.
    evidence:
    - reference: PMID:14756886
      supports: SUPPORT
      evidence_source: OTHER
      snippet: &#34;Lichen simplex chronicus frequently persists as an itch-scratch cycle&#34;
      explanation: Review evidence supports itch-scratch cycle in LSC.
    notes: Hypothesis only; evidence is descriptive, not causal.
- description: &gt;-
    Hypothesis: diabetic neuropathy and metabolic dysregulation increase chronic
    pruritus risk, promoting PN/LSC phenotypes in susceptible individuals. Evidence
    not yet curated.
  pathophysiology:
  - name: Neuropathic itch in diabetes
    description: &gt;-
      Diabetes-related peripheral neuropathy may manifest as chronic itch that
      perpetuates scratching and lesion formation.
    notes: Hypothesis only; evidence not yet curated.
- description: &gt;-
    Hypothesis: type 2 inflammatory mediators elevated in T2D patients with chronic
    pruritus (IL-4, IL-13, GM-CSF, CXCL10) could promote pruritic dermatoses such
    as PN/LSC.
  evidence:
  - reference: PMID:36852577
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Significantly higher levels of interleukin-4 (p = 0.004), interleukin-13 (p = 0.006), granulocyte-macrophage colony-stimulating factor (p &lt; 0.001) and C-X-C motif chemokine ligand 10 (p = 0.028) were observed in the patients with pruritus than in those without pruritus.&#34;
    explanation: T2D patients with pruritus show elevated type 2 and inflammatory mediators.
  pathophysiology:
  - name: Type 2 inflammatory mediators in diabetic pruritus
    description: &gt;-
      Elevated type 2 and inflammatory mediators in T2D-associated pruritus may
      amplify neuroimmune itch signaling and sustain pruritic dermatoses.
    mechanisms:
    - Interleukin-4 (IL-4)
    - Interleukin-13 (IL-13)
    - Granulocyte-macrophage colony-stimulating factor (GM-CSF)
    - CXCL10 (C-X-C motif chemokine ligand 10)
    biological_processes:
    - preferred_term: inflammatory response
      term:
        id: GO:0006954
        label: inflammatory response
    - preferred_term: cytokine-mediated signaling pathway
      term:
        id: GO:0019221
        label: cytokine-mediated signaling pathway
    - preferred_term: chemokine-mediated signaling pathway
      term:
        id: GO:0070098
        label: chemokine-mediated signaling pathway
    - preferred_term: response to interleukin-4
      term:
        id: GO:0070670
        label: response to interleukin-4
    - preferred_term: response to interleukin-13
      term:
        id: GO:0035962
        label: response to interleukin-13
    gene_products:
    - preferred_term: Interleukin-4
      term:
        id: NCIT:C20508
        label: Interleukin-4
    - preferred_term: Interleukin-13
      term:
        id: NCIT:C20515
        label: Interleukin-13
    - preferred_term: Granulocyte-Macrophage Colony-Stimulating Factor
      term:
        id: NCIT:C20545
        label: Granulocyte-Macrophage Colony-Stimulating Factor
    - preferred_term: C-X-C Motif Chemokine 10
      term:
        id: NCIT:C28756
        label: C-X-C Motif Chemokine 10
    evidence:
    - reference: PMID:36852577
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;Significantly higher levels of interleukin-4 (p = 0.004), interleukin-13 (p = 0.006), granulocyte-macrophage colony-stimulating factor (p &lt; 0.001) and C-X-C motif chemokine ligand 10 (p = 0.028) were observed in the patients with pruritus than in those without pruritus.&#34;
      explanation: Serum mediator elevations in pruritic T2D patients suggest inflammatory drivers.

association_signals:
- source: DISEASE_TRAJECTORIES
  method: EHR_TEMPORAL_COMORBIDITY
  signal_disorder_a_id: ICD10:E12
  signal_disorder_b_id: ICD10:L28
  population: Austrian hospital stays (EHR-derived)
  demographics:
    sex: MALE
  mapping_notes: &gt;-
    ICD10:L28 groups lichen simplex chronicus and prurigo. ICD10:E12 (malnutrition-related
    diabetes) may be a proxy for broader T2D biology in this EHR signal.
  directionality: A_BEFORE_B
  a_before_b: 1.0
  b_before_a: 0.0
  same_time: 0.0
  notes: Derived from distraj phase dict (E12-L28, male).
  go_enrichment:
    method: Disease Trajectories genetic overlap + GO enrichment
    description: GO enrichment for shared disease-gene module (EHR-derived).
    go_terms:
    - term:
        id: GO:0042593
        label: Glucose homeostasis
      fdr: 1.3316900932562691e-18
    - term:
        id: GO:0032869
        label: Cellular response to insulin stimulus
      fdr: 2.6548646247194685e-11
    - term:
        id: GO:0050796
        label: Regulation of insulin secretion
      fdr: 7.357708923593862e-11
- source: LITERATURE
  method: LITERATURE_ASSOCIATION
  population: Retrospective LSC cohort at a tertiary academic center (n=125).
  mapping_notes: Signal pertains to the Lichen_Simplex_Chronicus component.
  directionality: UNKNOWN
  statistics:
    metrics:
    - metric_type: PREVALENCE
      metric_value: 0.30
      notes: Reported T2D prevalence in LSC cohort; comparator ~11% US adult population.
    evidence:
    - reference: PMID:40908757
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;type 2 diabetes (30% vs ~11%).&#34;
      explanation: LSC cohort reported elevated T2D prevalence versus the general population.
- source: LITERATURE
  method: LITERATURE_ASSOCIATION
  population: Korean dermatology outpatient cohort (PN; 2007-2020).
  mapping_notes: Signal pertains to the Prurigo_Nodularis component.
  directionality: UNKNOWN
  statistics:
    metrics:
    - metric_type: AOR
      metric_value: 1.37
      metric_ci_lower: 1.22
      metric_ci_upper: 1.54
      notes: Adjusted odds ratio for T2D in PN vs controls.
    evidence:
    - reference: PMID:35011837
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;type 2 diabetes mellitus (aOR, 1.37; 95% CI, 1.22-1.54)&#34;
      explanation: PN outpatient cohort showed increased odds of T2D.
- source: LITERATURE
  method: LITERATURE_ASSOCIATION
  population: UK CPRD incident PN cohort (2008-2018).
  mapping_notes: Signal pertains to the Prurigo_Nodularis component.
  directionality: UNKNOWN
  statistics:
    metrics:
    - metric_type: RR
      metric_value: 1.836
      metric_ci_lower: 1.597
      metric_ci_upper: 2.111
      notes: Relative risk of T2D prevalence in PN vs matched controls.
    evidence:
    - reference: PMID:38024558
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;type 2 diabetes mellitus (RR = 1.836; 95% CI = 1.597-2.111)&#34;
      explanation: UK CPRD cohort found higher T2D prevalence among PN patients.

phenotypes:
- name: Pruritus
  description: Chronic itch shared across PN/LSC and reported in T2D cohorts.
  phenotype_term:
    preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  evidence:
  - reference: PMID:40855389
    supports: SUPPORT
    snippet: &#34;Lichen simplex chronicus (LSC), also known as neurodermatitis, is a common chronic pruritic dermatosis defined by lichenified plaques resulting from persistent scratching.&#34;
    explanation: LSC is described as a chronic pruritic dermatosis.
  - reference: PMID:38345154
    supports: SUPPORT
    snippet: &#34;intensely pruritic nodules on the skin.&#34;
    explanation: PN is characterized by intensely pruritic nodules.
  - reference: PMID:36852577
    supports: SUPPORT
    snippet: &#34;Chronic pruritus is an unpleasant sensory perception that negatively affects quality of life and is common among patients with type 2 diabetes mellitus.&#34;
    explanation: Chronic pruritus is common among patients with T2D.
- name: Sleep disturbance
  description: Sleep disruption associated with chronic itch in PN and LSC.
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:40855389
    supports: SUPPORT
    snippet: &#34;The hallmark itch-scratch cycle contributes not only to visible skin changes but also to substantial sleep disruption, emotional distress, and functional impairment.&#34;
    explanation: LSC review links itch-scratch cycle to sleep disruption.
  - reference: PMID:38345154
    supports: SUPPORT
    snippet: &#34;Patients with PN suffer from an intractable itch-scratch cycle leading to impaired sleep, psychosocial distress and a significant disruption in quality of life.&#34;
    explanation: PN review reports impaired sleep in association with itch-scratch cycle.
- name: Lichenification
  description: Lichenified plaques driven by chronic scratching in LSC.
  phenotype_term:
    preferred_term: Lichenification
    term:
      id: HP:0100725
      label: Lichenification
  evidence:
  - reference: PMID:40855389
    supports: SUPPORT
    snippet: &#34;Lichen simplex chronicus (LSC), also known as neurodermatitis, is a common chronic pruritic dermatosis defined by lichenified plaques resulting from persistent scratching.&#34;
    explanation: LSC is defined by lichenified plaques caused by persistent scratching.
- name: Skin nodule
  description: Pruritic nodules characteristic of prurigo nodularis.
  phenotype_term:
    preferred_term: Skin nodule
    term:
      id: HP:0200036
      label: Skin nodule
  evidence:
  - reference: PMID:38345154
    supports: SUPPORT
    snippet: &#34;intensely pruritic nodules on the skin.&#34;
    explanation: PN is characterized by pruritic nodules.
</pre>
            </details>
            
            <div class="field"><span class="field-label">Source:</span><a href="https://github.com/monarch-initiative/dismech/blob/main/kb/comorbidities/com_Type_2_Diabetes_Mellitus__Lichen_Simplex_Chronicus__Prurigo_Nodularis.yaml" target="_blank">GitHub</a></div>
            
        </div>
    </div>
</body>
</html>